Preferred Drug Lists and Medicaid Prescriptions

Tamer Abdelgawad () and Lisa Egbuonu-Davis

PharmacoEconomics, 2006, vol. 24, issue 3, 55-63

Abstract: Background: When Medicaid preferred drug lists (PDLs) are implemented, they may impose indirect costs on prescribing physicians and Medicaid patients, leading to an unintended reduction in the number of Medicaid prescriptions filled. Objective: To test retrospectively the proposition that PDLs adversely affect the number of Medicaid prescriptions filled. Data and methods: We compared three ‘test’ states (Alabama, Texas, and Virginia) that implemented PDLs with restrictions on the prescription of statins with three ‘control’ states (New Jersey, North Carolina, and Pennsylvania) that did not implement drug access restrictions. We conducted the analysis at the county level and used a differences-in-differences approach that allows for county and time-period fixed effects. Results: We found that PDLs adversely impacted several measures of filled Medicaid prescriptions in the ‘test’ states relative to the ‘control’ states. Conclusion: There are unintended but potentially harmful consequences to cost-focused health policy interventions. Copyright Adis Data Information BV 2006

Date: 2006
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://hdl.handle.net/10.2165/00019053-200624003-00005 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:24:y:2006:i:3:p:55-63

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.2165/00019053-200624003-00005

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().